Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer.
Future Drug Discov
; 1(1): FDD8, 2019 Jul.
Article
in En
| MEDLINE
| ID: mdl-31448368
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Future Drug Discov
Year:
2019
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido